Report identifies critical gaps and research opportunities for improved cancer care

December 16, 2020

ATLANTA - DECEMBER 16, 2020 - A new report finds that despite progress in the decline of cancer mortality, there are still critical gaps including the need to develop better tools and explore research opportunities that would lead to limiting cancer as a major health concern. This blueprint article completes an eight-part series outlining the American Cancer Society's (ACS) vision for the future control of cancer. The report focuses on highlighting research challenges and opportunities important to significantly change the future of cancer care. It appears in the ACS Journal, CA: A Cancer Journal for Clinicians.

Authored by Lynne W. Elmore, PhD, and colleagues, this piece integrates conversations with over 90 leading cancer experts to facilitate a comprehensive and diverse national research portfolio of new opportunities to advance evidence-based approaches for all cancer patients and communities. "Our overall goal is to motivate a strategy to develop innovative approaches for cancer prevention, interception, treatment, and improvement of quality of life for cancer survivors, and these findings present incredible potential for collaboration and clinical impact," write the authors.

The report highlights a gap in cancer care related to inconsistent coordination between researchers and caregivers. In the article, the authors point out the need to narrow knowledge gaps in understanding the biology of cancer development in early stages and its treatment resistance to ensure that all cancer patients can be provided cancer care that is effective, practical and affordable. They also believe that success depends on the need to develop the next generation of tools to understand, prevent, and better control all cancer types. In 2019, only about one-half of patients with cancer in the United States could be cured with existing therapies, and the remaining one-half were expected to die of their disease. In addition, while data shows that therapeutic interventions have improved significantly, chronic comorbidities often adversely affect cancer survivors and their quality of life.

The authors also note that maximizing opportunities for clinical impact requires a focus on broad-based integration of research efforts including data sets, cancer models, and testing combinatorial strategies to screen, detect and diagnose cancers. Other opportunities for research integration include forming transdisciplinary scientific teams, increasing the recruitment of ethnically and racially diverse populations in clinical trials, and testing innovative strategies to improve cancer prevention, diagnosis, treatment and survivorship in underserved communities.

"Our ability to manage cancer as a chronic disease will continue to grow and demand increased investments in survivorship research to maximize quality of life for people with cancer, their families and caregivers," said Elmore. "While it can appear daunting to consider all that needs to be done in research to conquer the hundreds of diseases we group together under the moniker of cancer, this report shows that if we continue to collaborate and leverage collective resources progress can continue to be made in the future of cancer care."
Article: Elmore LW, Greer SF, Daniels EC, Saxe CC, Melner MH, Krawiec GM, Cance WG, Phelps WC. Blueprint for Cancer Research: Critical Gaps and Opportunities; CA Cancer J Clin. doi:10.3322/caac.21652

URL upon embargo:

American Cancer Society

Related Cancer Articles from Brightsurf:

New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

Read More: Cancer News and Cancer Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to